Tenet (THC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Core Insights - Tenet Healthcare reported revenue of $5.12 billion for the quarter ended September 2024, reflecting a year-over-year increase of 1.1% and surpassing the Zacks Consensus Estimate of $5.05 billion by 1.48% [1] - The company's EPS for the quarter was $2.93, significantly higher than the $1.44 reported in the same quarter last year, and exceeded the consensus estimate of $2.33 by 25.75% [1] Financial Performance Metrics - Net Operating Revenues were $5.12 billion, compared to the three-analyst average estimate of $5.05 billion, marking a year-over-year change of +1.1% [3] - Net Operating Revenues from Ambulatory Care reached $1.14 billion, exceeding the average estimate of $1.07 billion, with a year-over-year increase of +21% [3] - Net Operating Revenues from Hospital Operations and other segments totaled $3.98 billion, slightly above the average estimate of $3.96 billion, reflecting a year-over-year change of +1.6% [3] - Adjusted EBITDA for Hospital Operations and other was reported at $539 million, surpassing the average estimate of $473.79 million [3] - Equity in earnings of unconsolidated affiliates was $62 million, compared to the average estimate of $64.09 million [3] - Adjusted EBITDA for Ambulatory Care was $439 million, slightly above the average estimate of $432.72 million [3] Stock Performance - Tenet's shares have declined by 16.1% over the past month, while the Zacks S&P 500 composite has increased by 1.7% [4] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [4]